RxSight (RXST) Accumulated Expenses (2020 - 2026)
RxSight's (RXST) quarterly Accumulated Expenses came in at $18.7 million in Q1 2026, up 28.63% YoY from $14.6 million in Q1 2025, and down 5.29% on a QoQ basis from $19.8 million in Q4 2025.
RxSight (RXST) Accumulated Expenses (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Accumulated Expenses data on file, last reported at $18.7 million in Q1 2026.
- Quarterly Accumulated Expenses rose 28.63% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (up 28.63% YoY) and the FY2025 annual result came in at $19.8 million, down 2.77% from the prior year.
- Accumulated Expenses slipped to $18.7 million in Q1 2026, from $19.8 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $20.4 million in Q4 2024 to a low of $6.4 million in Q1 2022.
- A 5-year average of $13.8 million and a median of $13.8 million in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses soared 70.35% — and 2025, when it declined 2.77%.
- Tracing RXST's Accumulated Expenses over 5 years: stood at $12.7 million in 2022, then gained by 20.26% to $15.2 million in 2023, then soared by 33.59% to $20.4 million in 2024, then fell by 2.77% to $19.8 million in 2025, then dropped by 5.29% to $18.7 million in 2026.
- The last three Accumulated Expenses figures came in at $18.7 million (Q1 2026), $19.8 million (Q4 2025), and $17.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.55 Mn |
| Mar 31, 2026 | 18.75 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Sep 30, 2025 | 17.62 Mn |
| Jun 30, 2025 | 15.93 Mn |
| Mar 31, 2025 | 14.58 Mn |
| Dec 31, 2024 | 20.36 Mn |
| Sep 30, 2024 | 17.32 Mn |
| Jun 30, 2024 | 13.79 Mn |
| Mar 31, 2024 | 11.66 Mn |
| Dec 31, 2023 | 15.24 Mn |
| Sep 30, 2023 | 12.86 Mn |
| Jun 30, 2023 | 10.59 Mn |
| Mar 31, 2023 | 9.18 Mn |
| Dec 31, 2022 | 12.67 Mn |
| Sep 30, 2022 | 10.25 Mn |
| Jun 30, 2022 | 7.88 Mn |
| Mar 31, 2022 | 6.41 Mn |
| Dec 31, 2021 | 7.86 Mn |
| Sep 30, 2021 | 6.02 Mn |